Med-IQ Logo
Get CME/CE
E-publication E-publication

Emerging Science and Expert Perspectives: Incorporating Updates From the Annual Hematology Meeting Into Practice


Time to complete:
75 minutes
Released:
3/7/14
Expires:
3/6/15

Maximum Credits:

1.25 AMA PRA Category 1 Credit(s)

E-publicationE-publication
Time to complete:
75 minutes

Released:
3/7/14

Expires:
3/6/15

Maximum Credits:
1.25 AMA PRA Category 1 Credit(s)
Share on:
E-publicationE-publication

Share on:


Time to complete:
75 minutes
Released:
3/7/14
Expires:
3/6/15


Maximum Credits:
1.25 AMA PRA Category 1 Credit(s)


Overview: The annual hematology meeting offers world-renowned clinicians the opportunity to present cutting-edge data on the latest advances in the management of hematologic malignancies. This publication summarizes key findings that were presented at the 2013 meeting in acute leukemia, lymphoma, and multiple myeloma. It also includes short video clips of on-site expert faculty interviews that provide insight on how the data affect overall disease management and future strategies. Participants who would like to view the full-length videos or read the full-length video transcripts can access those materials in the “non-credit supplemental educational material” box below and to the right.

Faculty

Luciano J. Costa, MD, PhD
Associate Professor of Medicine
Department of Medicine and UAB-CCC
Bone Marrow Transplantation and Cell Therapy Program
School of Medicine
University of Alabama at Birmingham
Birmingham, AL

Scott C. Howard, MD, MSc
Adjunct Professor
University of Memphis
Memphis, TN

Joseph Mikhael, MD, MEd, FRCPC, FACP
Associate Dean, Mayo School of Graduate Medical Education
Deputy Director of Education, Mayo Clinic Cancer Center
Associate Professor, Mayo College of Medicine
Mayo Clinic
Scottsdale, AZ

William Mencia MD
Moderator
Vice President, Education and Medical Affairs
Med-IQ
Baltimore, MD


Disclosure Policy

Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.


Disclosure Statement

The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.  

Luciano J. Costa, MD, PhD
Fees received for promotional/non-CME activities: Sanofi-aventis U.S. Inc.
Contracted research: Gilead Sciences, Inc., Sanofi-aventis U.S. Inc.
 
Scott C. Howard, MD, MSc
Consulting fees (eg, advisory boards): Sanofi-aventis U.S. Inc., Sigma-Tau Pharmaceuticals, Inc.
 
Joseph Mikhael, MD, MEd, has indicated no real or apparent conflicts.
 
William Mencia, MD, has indicated no real or apparent conflicts. 


The writer, activity planners, and peer reviewers have no financial relationships to disclose.


This activity has been approved for AMA PRA Category 1 Credit™.


This activity is supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc., Onyx Pharmaceuticals, and Seattle Genetics, Inc.

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.
Play Video
The trifecta of healthcare improvement: value-based care, quality improvement, and technology.

See how Med-IQ is helping to enhance patient outcomes in these short videos.

Scott Weber, CEO Med-IQ

From Volume to Value-Based Care: The Role of the CME Enterprise

Scott Weber, CEO,
Med-IQ

Allison Gardner, PhD, VP Educational Strategy and Content, Med-IQ

The Value of Quality Improvement and Education to Advance Healthcare

Allison Gardner, PhD,
VP Educational Strategy and Content,
Med-IQ

Dr. Glenn Treisman,
Department of Psychiatry, Johns Hopkins Medical Institute

The Pros and Cons of Technology on the Practice of Medicine

Dr. Glenn Treisman,
Department of Psychiatry,
Johns Hopkins Medical Institute


Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com. For technical assistance, please refer to our support manual.